FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to pyrazolopyrimidine derivatives or a stereoisomer thereof selected from the group consisting of following compounds 1–18:
Invention also relates to a pharmaceutical composition having Janus kinase 1 (JAK1) inhibitory activity based on said compounds.
EFFECT: obtaining novel compounds and a pharmaceutical composition based on said compounds, which can be used in medicine for treating a disease or a condition responding to inhibition of Janus kinase activity.
23 cl, 2 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
PYRIDOPYRIMIDINONES AND USE THEREOF AS MODULATORS OF N-METHYL-D-ASPARTATE RECEPTOR | 2016 |
|
RU2717665C2 |
DERIVATIVES OF 1-PHENYL-2-PYRIDINYL-ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2637945C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
2-PYRAZINONE DERIVATIVES FOR TREATING DISEASES OR CONDITIONS WHERE INHIBITING NEUTROPHIL ELASTASE ACTIVITY IS USEFUL | 2007 |
|
RU2448098C2 |
COMPOUNDS 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE | 2017 |
|
RU2719599C2 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2678305C1 |
Authors
Dates
2022-04-05—Published
2018-05-21—Filed